A Double-blind, Placebo-controlled, Randomized Study Evaluating the Effect of Paliperidone ER Compared With Placebo on Sleep Architecture in Subjects With Schizophrenia.
Phase of Trial: Phase II
Latest Information Update: 20 May 2010
At a glance
- Drugs Paliperidone (Primary)
- Indications Insomnia; Schizophrenia
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Janssen Research & Development
- 20 May 2010 Actual patient number added as 5 as reported by ClinicalTrials.gov.
- 05 May 2010 New trial record